Condition: Fecal Incontinence · Sponsor: Innovacell GmbH
The objective of this study is the final assessment of clinical safety and efficacy of autologous autologous skeletal muscle derived cells for patients with urge fecal incontinence due to external anal sphincter dysfunction caused by its disruption and/or weakness.
This description comes directly from the study's public registry record.
Innovacell · +43512573680 · office@innovacell.com
Always discuss trial participation with your own doctor first.
| Medical University Graz | Graz, Austria | Recruiting |
| Landeskrankenhaus Hall in Tirol | Hall in Tirol, Austria | Recruiting |
| Medical Center Unimed EOOD | Sevlievo, Bulgaria | Recruiting |
| Fakultni nem. u sv. Anny v Brne | Brno, Brno, Czechia | Recruiting |
| The Institute for the Care of Mother and Child | Prague, Czechia | Recruiting |
| Deaconess Hospital Group Croix Saint - Simon | Paris, France, France | Recruiting |
| Hospital Bichat - Claude Bernard | Paris, France, France | Recruiting |
| CHU Rennes - Hospital Pontchaillou | Rennes, France | Recruiting |
| CHU de Rouen | Rouen, France | Recruiting |
| Magen Darm Zentrum Wiener Platz | Cologne, North Rhine-Westphalia, Germany | Recruiting |
| Heidelberg University, Medical Faculty Mannheim, Department of surgery | Mannheim, Germany | Recruiting |
| I.R.C.C.S. Policlinico San Donato | San Donato Milanese, Milano, Italy | Recruiting |
+ 22 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04976153